IMODIUM DUO 2/125 MG 18 TABL

Description

Imodium® Duo tablets are used for the symptomatic treatment of acute diarrhoea accompanied by abdominal cramps and bloating. The tablets contain 2 mg loperamide and 125 mg simeticone, an active ingredient that relieves the unpleasant sensation of gas in the intestines. Imodium® Duo tablets are suitable when acute diarrhoea is accompanied by cramps, bloating and flatulence. Loperamide, or loperamide hydrochloride, reduces diarrhoea by slowing down increased intestinal activity. This active ingredient also promotes the absorption of fluids and electrolytes, preventing dehydration. The other active ingredient, simeticone, helps dissolve the gas responsible for cramps and bloating in the intestine, providing relief. Imodium® Duo is available without prescription. Always read the leaflet.

• Recommended for the symptomatic treatment of diarrhoea accompanied by abdominal cramps and flatulence.
• The two active ingredients, loperamide and simeticone, in Imodium® Duo tablets have a dual effect.
• Loperamide treats acute diarrhoea quickly, safely and effectively by slowing down increased intestinal activity.
• Simeticone relieves the unpleasant sensation of bloating and flatulence.
• Imodium® Duo prevents fluid and electrolyte loss and eliminates the formation of gas in the abdomen. Antispasmodic effect. – Imodium® Duo is available without prescription. Always read the package leaflet.

Imodium® Duo is a medicine. Always read the patient information leaflet. Do not take Imodium® Duo for more than 2 days without medical advice. Never take more than 4 tablets in 24 hours. The initial dose is 2 tablets for adults and 1 tablet for children aged 12 and over. If necessary, take 1 tablet after each liquid stool.

• Known hypersensitivity to the active substance or to one of the excipients.
• Children under 12 years of age.
• Patients with fructose intolerance, glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases).
• Patients with acute dysentery, characterised by blood in the stools and high fever, patients with acute ulcerative colitis, patients with pseudomembranous colitis or patients with bacterial enterocolitis.
• Imodium Duo cannot be used when inhibition of peristalsis must be avoided.
• Active ingredients (per tablet): 2 mg loperamide hydrochloride and simethicone equivalent to 125 mg dimethicone.
• Excipients: anhydrous hydrogenated calcium phosphate, microcrystalline cellulose, acesulfame potassium, synthetic vanilla flavour (including propylene glycol, maltodextrin and benzyl alcohol), sodium starch glycolate (type A), stearic acid.
• Drugs with comparable pharmacological properties.
• Concomitant administration of loperamide with quinidine or ritonavir.
• Concomitant administration of loperamide with itraconazole and ketoconazole.
• Concomitant treatment of loperamide with oral desmopressin.